-
Battle Of Wealth And Wits: Elon Musk Is The World's Richest But How Does His Genius Stack Up Against Jeff Bezos, Mark Zuckerberg?
Thursday, October 19, 2023 - 6:30pm | 444Although Tesla Inc (NASDAQ: TSLA) CEO Elon Musk is the richest person in the world, he may not be as smart as some of his billionaire peers, according to new data used to assess general intelligence. What To Know: According to a report from The Street citing online tutoring...
-
Cannabis Movers & Shakers: MA Cannabis Commissioner Chair Resigns, Management Shake-Ups At The Source+, NatureTrak & Global Sciences
Wednesday, May 4, 2022 - 9:22am | 710Steven Hoffman Steps Down As Chair Of Massachusetts Cannabis Commission Steven Hoffman resigned from his position recently, reported NBC Boston. Massachusetts Cannabis Control Commission Chairman spokesperson confirmed on Monday that Hoffman stepped down on April 25, though the ...
-
3 Stocks To Buy To Beat Inflation According To This Wall Street Veteran
Monday, March 21, 2022 - 5:16pm | 397Fed Chairman Jerome Powell said on Monday that inflation is too high and that the FED is ready to take action as needed. Powell’s tone has shifted tremendously since last year, when he described the inflation we were seeing as "transitory," meaning that it would soon pass. ...
-
Cashless Bank Transfers For Cannabis Companies? 22 Governors Say Yes And Take Their Case To Congress
Thursday, November 11, 2021 - 11:56am | 482Politicians, some of them, have finally decided to do something about the seemingly endless cannabis banking problem. Colorado Governor Jared Polis, Michigan Governor Gretchen Whitmer and 20 other state governors signed a letter demanding that Congress pass the Secure and Fair Enforcement...
-
Soros Fund Management Trades Bitcoin, Considers Acquiring Blockchain Companies: Report
Thursday, July 1, 2021 - 4:38pm | 382Soros Fund Management, the private investment firm of billionaire George Soros, is now trading Bitcoin (CRYPTO: BTC) and considering acquiring crypto and blockchain companies. What Happened: According to The Street, over the last few weeks, Soros Fund Management's Chief...
-
Cramer Slams Sundial As Cannabis Company Raises Over $89M Via Warrant Exchange
Friday, February 19, 2021 - 12:52pm | 642Sundial Growers Inc. (NASDAQ: SNDL) reported Friday that it has raised $89.1 million via a warrant exchange. The company noted that holders of 98.33 million warrants to buy shares of the company will exercise for cash their warrants at prices of 80 cents and $1.10 for gross proceeds to the company...
-
Canopy Growth Soars On Unexpected Guidance Update, European Acquisition
Tuesday, April 16, 2019 - 1:38pm | 578Canopy Growth Corp (NYSE: CGC) shares surged more than 4 percent after co-CEO Bruce Linton updated the company’s fiscal 2020 revenue guidance Tuesday at the GMP Securities cannabis conference in Toronto. What Happened Canopy anticipates at least $744 million in revenue in...
-
'Riding So More Jimmy's Can Ring The Bell': TheStreet's Adam Feuerstein To Bike For Jimmy Fund, Dana-Farber Cancer Institute
Thursday, May 4, 2017 - 2:26pm | 340Since 1980, tens of thousands of cyclists have ridden in the Pan-Mass Challenge to raise a total of $547 million for the Jimmy Fund of the Dana-Farber Cancer Institute. The race proceeds are the Institute's greatest contribution and comprise more than 50 percent of the Jimmy Fund’s annual...
-
The Bull-Bear Debate In Therapeutics Rages From Research Notes To Twitter
Thursday, April 20, 2017 - 9:24am | 521TherapeuticsMD Inc (NYSE: TXMD) has waned as much as 40 percent since April 7, when the company received an FDA letter noting deficiencies in the new drug application for vulvovaginal atrophy treatment, Yuvvexy (TX-004HR). The regulatory agency said the deficiencies preclude talk of the drugs...
-
Feuerstein Throws BioMarin Into Gilead Takeover Speculation
Wednesday, April 5, 2017 - 11:28am | 476When people talk Gilead Sciences, Inc. (NASDAQ: GILD) takeover possibilities, TESARO Inc (NASDAQ: TSRO) and Incyte Corporation (NASDAQ: INCY) commonly surface. But biotech reporter Adam Feuerstein posited a less conventional interest — orphan-drug company BioMarin Pharmaceutical Inc. (NASDAQ...
-
Amgen's Repatha Results Not Good Enough For The Street
Friday, March 17, 2017 - 9:42am | 432Shares of Amgen, Inc. (NASDAQ: AMGN) fell 7 percent after the biotechnology company released data from its therapy called Repatha, which is used to lower the risk of heart attacks, strokes and heart problems. Amgen reported Repatha reduces the risk of heart attacks, stokes and other heart-related...
-
Price Action Comparisons Notwithstanding, Mario Could Be Nintendo's Financial Boon In A Way 'Pokémon GO' Never Was
Friday, December 16, 2016 - 3:22pm | 414Nintendo Co., Ltd (ADR) (OTC: NTDOY) may have hit the jackpot with its " Super Mario Run," as it launched its first full-blown mobile game Thursday. The Japanese company has had its fair share of success as a video gaming console company. Having started out as an unparalleled leader, the company...
-
Chipotle Exec: We're Not Recovering Like We Hoped
Tuesday, December 6, 2016 - 10:50am | 456Chipotle Mexican Grill, Inc. (NYSE: CMG) opened Tuesday’s session down more than 7.5 percent following yet another disappointing quarterly report. Disappointment Continues A number of food safety issues plagued the company throughout late 2015 and early 2016, including multiple...
-
Foot Locker Should Benefit From Favorable Industry Tailwinds
Wednesday, November 2, 2016 - 10:25am | 323Wedbush’s Christopher Svezia believes a 13 percent premium multiple is justified for Foot Locker, Inc. (NYSE: FL), given the company’s “global dominance in athletic footwear and the ability to navigate and adapt to consumer preferences.” Svezia initiated coverage of the...
-
The Startup That Wants To Bring Expert Networks To Every Investor
Wednesday, October 19, 2016 - 4:40pm | 1522Professional investors spend over $600 million per year speaking with the most qualified experts before risking their capital. Until now, this information was unavailable to most investors. But Slingshot Insights is trying to change that by offering every investor access to the same insiders...